INM Earnings

Quarterly EPS
$-4.05
Q4 2024
$-2.71
Q1 2025
$-3.64
Q2 2025
$-1.94
Q3 2025
$-1.21
Q4 2025
$-0.44
Q1 2026
$-0.51
Q2 2026
$-0.73
Q3 2026
Latest RevenueN/A
Latest Net Income-2966336
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.730-2966336+62.4%
Q2 2026-$0.51820.2K-2028223-26.2%+86.0%
Q1 2026-$0.441.1M-1726899-11.4%+83.8%
Q4 2025-$1.211.3M-1788311+1.7%+70.1%
Q3 2025-$1.940-2120930-100.0%+45.8%
Q2 2025-$3.641.1M-2575024-10.4%+1.9%
Q1 2025-$2.711.3M-1677868+40.2%+99.1%
Q4 2024-$4.051.3M-1937671-44.5%-97.6%
Q3 2024-$3.581.2M-1722866
Q2 2024-$3.711.2M-1478185
Q1 2024-$304.80901.9K-2536828
Q4 2023-$2.052.3M-338391
InMed Pharmaceuticals Inc. Common Shares (INM) — Earnings